Stay updated on CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Sign up to get notified when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.

Latest updates to the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page
- Check5 days agoChange DetectedThe page has updated its dates, removing the date '2025-04-11' and adding '2025-04-22' and '2025-04-19'. Additionally, the number '116' has been replaced with '126'.SummaryDifference0.8%
- Check12 days agoChange DetectedThe webpage has undergone significant updates, including the addition of a new revision date and the introduction of a new study focusing on a dual-targeted CAR T-cell therapy for B-cell malignancies. The previous background information on acute lymphoblastic leukemia (ALL) has been removed, which may impact the context of the study.SummaryDifference47%
- Check20 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and has added new dates for April 2025 while removing older dates from February and March 2025.SummaryDifference0.7%
- Check27 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 26, 2025, and version 2.14.2.SummaryDifference0.7%
- Check34 days agoChange DetectedDifference0.5%
- Check42 days agoChange DetectedDifference0.3%
Stay in the know with updates to CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.